Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. <i>Vaccines</i> 2024, <i>12</i>, 974. [PDF]
Feemster K +8 more
europepmc +1 more source
Pneumococcal vaccine hyporesponsiveness in people living with HIV: A narrative review of immunological mechanisms and insights from minimally invasive lymph node sampling. [PDF]
Loe-Sack-Sioe GE +4 more
europepmc +1 more source
Reports of Injection Site Necrosis After 23-Valent Pneumococcal Vaccine Use.
Day B +3 more
europepmc +1 more source
Pneumococcal Vaccine Use and Immunogenicity in Patients with Glomerular Disease: A Scoping Review and Analysis of Healthcare Claims Data. [PDF]
Guittari KE +6 more
europepmc +1 more source
Outpatient Visits and Antibiotic Use Due to Higher-Valency Pneumococcal Vaccine Serotypes. [PDF]
King LM +7 more
europepmc +1 more source
Regional differences in pediatric pneumococcal vaccine schedules for Indigenous children in Canada: an environmental scan. [PDF]
Mahon S +3 more
europepmc +1 more source
<i>Streptococcus pneumoniae</i> serotype distribution in low- and middle-income countries of South Asia: Do we need to revisit the pneumococcal vaccine strategy? [PDF]
Dhawale P +8 more
europepmc +1 more source

